Navigation Links
Ipsen Biopharmaceuticals Joins National Pharmaceutical Council
Date:3/28/2017

WASHINGTON, March 28, 2017 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Ipsen Biopharmaceuticals, Inc. has joined the health policy research organization as its newest member. David Cox, PhD, Vice President, Medical and Regulatory Affairs (North America), will serve as his company's representative on NPC's Board of Directors.

"We're pleased to have Ipsen and Dr. Cox join NPC as members," said NPC President Dan Leonard. "We welcome their insights in helping us identify and address health care priorities in today's rapidly changing policy environment."

Ipsen Biopharmaceuticals, Inc. is the U.S. affiliate of Ipsen, a global specialty-driven pharmaceutical group focused on discovering, developing and commercializing new therapeutic options for oncologic, neurologic and endocrine diseases.

"At a time when all of us in health care are facing a number of challenges, we appreciate NPC's thoughtful, research-oriented approach in considering how to improve health system efficiencies and lower access barriers to high-value care, among other issues," said Dr. Cox. "We're looking forward to engaging with NPC on these important health care matters."

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.

About Ipsen in North America
Ipsen Biopharmaceuticals, Inc. is the U.S. affiliate of Ipsen, a global specialty-driven pharmaceutical group. The U.S. head office is located in Basking Ridge, New Jersey. Ipsen Biopharmaceuticals Canada, Inc. is an integrated business unit within North America and has its head office located in Mississauga, Ontario. Ipsen Bioscience, Inc., the Ipsen U.S. research and development center focused on peptide research in oncology and endocrinology, is located in Cambridge, Massachusetts. At Ipsen Bioscience, we focus on creating a highly cooperative and passionate R&D organization through partnerships, innovation, and continuous learning to effectively deliver new treatments for patients. At Ipsen, we focus our resources, investments, and energy on discovering, developing, and commercializing new therapeutic options for oncologic, neurologic, and endocrine diseases. For more information on Ipsen in North America, please visit www.ipsenus.com or www.ipsen.ca.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ipsen-biopharmaceuticals-joins-national-pharmaceutical-council-300429896.html


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. New 62,600 Square Foot Lease At 650 East Kendall Street Signed By Ipsen And BioMed Realty
2. Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors
3. Ipsen and EpiVax collaborate to produce next generation botulinum toxins
4. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
5. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
6. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
7. PolyTherics and Antitope Combine to Create Leading Provider of Solutions to Enable the Development of Better Biopharmaceuticals
8. Gallus BioPharmaceuticals Enters Clinical Supply Agreement with Genzyme for Niemann-Pick Type B Disease
9. Before the Bell Scans: Hologic Inc., St. Jude Medical Inc., ResMed Inc., and Navidea Biopharmaceuticals Inc.
10. Life Cycle Management of Biopharmaceuticals, New Life Science Webinar Hosted by Xtalks
11. Biopharmaceuticals - A Global Market Overview
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2018)... LINDA, Calif. (PRWEB) , ... August 23, 2018 ... ... virtual events for tech innovators, engineers, and scientists from around the world, will ... Immunology 2018 will cover an array of industries and disciplines, encompassing various research ...
(Date:8/21/2018)... (PRWEB) , ... August 21, ... ... a software company specializing in medical device compliance and commercialization, has just ... Cockpit® platform. , Written and presented by Dr. Mario Kossmann, ESEP at ...
(Date:8/17/2018)... ... August 16, 2018 , ... Ambry Genetics Corporation (“Ambry”), a ... were published today in JAMA Oncology, identifying new and confirming known hereditary breast ... Every year hereditary breast cancer affects more than 20,000 women while hereditary ovarian ...
(Date:8/14/2018)... ... August 14, 2018 , ... The ... 11th Congress of the Chinese Association of Orthopaedic Surgeons (CAOS) held in partnership ... & Technology Development , Beijing, and Invibio Biomaterial Solutions partnered to ...
Breaking Biology Technology:
(Date:9/7/2018)... ... September 05, 2018 , ... Following up on the ... last year, IPS-Integrated Project Services, LLC and G-CON Manufacturing have successfully designed and ... iCON solution provides a pre-fabricated modular cleanroom infrastructure for the drug manufacturers’ requirements ...
(Date:8/31/2018)... ... August 30, 2018 , ... CallTower is pleased to announce Jason ... of telecommunications experience and over ten years in executive leadership. Prior to joining CallTower, ... in early 2018. , In this new role, Jason will manage ...
(Date:8/29/2018)... ... August 28, 2018 , ... Johanna Dwyer, founder ... recognizes women of excellence in the field of intellectual property, and named Daniela ... Women in IP Award aims to encourage and support women in their pursuit ...
Breaking Biology News(10 mins):